Anti-SKP2 antibody [EPR3305(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
3
(1 Review)
|
(25 Publications)
Rabbit Recombinant Monoclonal SKP2 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Mouse, Rat, Human samples. Cited in 25 publications.
View Alternative Names
FBXL1, SKP2, S-phase kinase-associated protein 2, Cyclin-A/CDK2-associated protein p45, F-box protein Skp2, F-box/LRR-repeat protein 1, p45skp2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SKP2 antibody [EPR3305(2)] (AB183039)
immunohistochemical analysis of paraffin embedded Human kidney clear cell carcinoma tissue labeling SKP2 with ab183039 at 1/50 followed by secondary staining with Ready to use HRP Polymer for Rabbit IgG and counterstained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-SKP2 antibody [EPR3305(2)] (AB183039)
Intracellular flow cytometric analysis of 2% paraformaldehyde fixedHeLa cells labeling SKP2 with ab183039 at 1/70 followed byGoat anti rabbit IgG (FITC) at 1/150.Rabbit monoclonal IgG was used asIsotype control.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-SKP2 antibody [EPR3305(2)] (AB183039)
Immunofluorescenct analysis of 4% paraformaldehyde fixed 293T cells labeling SKP2 with ab183039 at 1/100 followed by Goat anti rabbit IgG(Alexa Fluor® 488) at 1/200 (green). Cells were counter stained with Dapi (blue).
- WB
Lab
Western blot - Anti-SKP2 antibody [EPR3305(2)] (AB183039)
Lanes 1 - 4 : Merged signal (red and green). Green - ab183039 observed at 52 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab183039 was shown to recognize in wild-type HAP1 cells as signal was lost at the expected MW in SKP2 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and SKP2 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% NF Milk. ab183039 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/200 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-SKP2 antibody [EPR3305(2)] (ab183039) at 1/200 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
SKP2 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MCF7 whole cell lysate at 20 µg
Predicted band size: 45 kDa,47 kDa,55 kDa
Observed band size: 45 kDa,55 kDa
false
- WB
Lab
Western blot - Anti-SKP2 antibody [EPR3305(2)] (AB183039)
We recommend to increase the amount of samples or decrease antibody dilution to get clear bands.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-SKP2 antibody [EPR3305(2)] (ab183039) at 1/200 dilution
Lane 1:
NCCIT (Human pluripotent embryonic carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 2:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 3:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 4:
Jurkat (Human T cell leukemia T lymphocyte) whole cell lysates at 20 µg
Lane 5:
MDA-MB-231 (Human breast adenocarcinoma epithelial cell) whole cell lysates at 20 µg
Lane 6:
A549 (Human lung carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 7:
F9 (Mouse embryonal carcinoma epithelial cell) whole cell lysates at 20 µg
Lane 8:
NIH/3T3 (Mouse embryonic fibroblast) whole cell lysates at 20 µg
Lane 9:
C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 47 kDa
false
Exposure time: 180s
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SKP2 antibody [EPR3305(2)]
-
Anti-SKP2 antibody [EPR3305(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SKP2 is part of the SCF (SKP1-CUL1-F-box) complex which is instrumental in controlling cell cycle and cell division. It regulates the degradation of p27^Kip1 and other cell cycle regulators. By modulating proteolysis SKP2 contributes to the maintenance of cell proliferation and it has essential roles in cellular responses to growth signals. Moreover SKP2 influences processes such as DNA replication through its effect on substrate interaction and ubiquitination.
Pathways
SKP2 functions inside the ubiquitin-proteasome system and impacts the PI3K/AKT signaling pathway. SKP2 advances cell cycle progression by associating with proteins like p27^Kip1 and CDK2 facilitating cell division. It modulates the phosphorylation state of numerous targets influencing signaling processes that control cell growth. This involvement aligns SKP2 with key cellular pathways that maintain cell survival and metabolic balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (25)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:22649 PubMed40595023
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine (Cambridge, Mass.) 31:65 PubMed39972431
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science signaling 17:eadk4122 PubMed39689183
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 98:e0135624 PubMed39475279
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of dermatology 36:282-291 PubMed39343755
2024
Applications
Unspecified application
Species
Unspecified reactive species
Medicina (Kaunas, Lithuania) 60: PubMed39064589
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 14:1418951 PubMed39011477
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular oncology 17:2126-2146 PubMed37491794
2023
Applications
Unspecified application
Species
Unspecified reactive species
Endocrine connections 12: PubMed36662677
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecules and cells 46:360-373 PubMed36694914
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com